Susanne Luedtke
Biographic Data
| ID | 9799897 |
|---|---|
| NAME | Susanne Luedtke |
| GIVEN NAMES | Susanne |
| FAMILY NAME | Luedtke |
| SIGNATURE | LUEDTKE S |
| AFFILIATIONS | National Science and Technology Center for Disaster Reduction |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Analyses of reported severe adverse events after immunization with Sars-CoV-2 vaccines in the United States
Objective: To analyze rates of reported severe adverse events after immunization (sAEFI) attributed to SARS-CoV-2 vaccines in the United States (US) using safety surveillance data. Methods: Observational study of sAEFI reported to the vaccine adverse events reporting system (VAERS) between December 13, 2020, to December 13, 2021, and attributed to SARS-CoV-2 vaccination programs across all US states and territories. All sAEFI in conjunction with …
National health governance, science and the media
The COVID-19 pandemic is an unprecedented global crisis in which governments had to act in a situation of rapid change and substantial uncertainty. The governments of Germany, Sweden and the UK have taken different paths allowing learning for future pandemic preparedness. To help inform discussions on preparedness, inspired by resilience frameworks, this paper reviews governance structures, and the role of science and the media in the COVID-19 re…
No prominent works on this page.
National health governance, science and the media
The COVID-19 pandemic is an unprecedented global crisis in which governments had to act in a situation of rapid change and substantial uncertainty. The governments of Germany, Sweden and the UK have taken different paths allowing learning for future pandemic preparedness. To help inform discussions on preparedness, inspired by resilience frameworks, this paper reviews governance structures, and the role of science and the media in the COVID-19 re…
Analyses of reported severe adverse events after immunization with Sars-CoV-2 vaccines in the United States
Objective: To analyze rates of reported severe adverse events after immunization (sAEFI) attributed to SARS-CoV-2 vaccines in the United States (US) using safety surveillance data. Methods: Observational study of sAEFI reported to the vaccine adverse events reporting system (VAERS) between December 13, 2020, to December 13, 2021, and attributed to SARS-CoV-2 vaccination programs across all US states and territories. All sAEFI in conjunction with …
Medicine (2 works) · Adverse effect (1 work) · Adverse Event Reporting System (1 work) · Antibody (1 work) · Business (1 work) · Cohort (1 work) · Confidence interval (1 work) · Corporate governance (1 work) · COVID-19 epidemiological studies (1 work) · Cumulative incidence (1 work)